Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 53.50
+0.50 (0.94%)
Feb 13, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 34.71 billion as of February 13, 2026. Its market cap has increased by 1,000.06% in one year.
Market Cap
34.71B
Enterprise Value
34.85B
Revenue
1.30B
Ranking
n/a
PE Ratio
146.61
Stock Price
53.50
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 34.71B, an increase of 236.53%. That is a compound annual growth rate of 42.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 34.71B | 47.17% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 61.19B |
| RemeGen | 59.51B |
| Shanghai Henlius Biotech | 39.10B |
| Shanghai Junshi Biosciences | 36.69B |
| Duality Biotherapeutics | 29.91B |
| TransThera Sciences (Nanjing) | 28.49B |
| Genscript Biotech | 27.40B |
| InnoCare Pharma | 26.45B |